← Back to Search

Preservative Free Morphine for Opioid Use/Abuse

Phase 4
Waitlist Available
Led By Daniel Katz, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

This trial is testing whether preservative-free morphine or placebo given after delivery can help with pain relief for patients who have had a neuraxial anesthetic.

Eligible Conditions
  • Opioid Use/Abuse
  • Postpartum Pain
  • Postpartum Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid Consumption
Secondary outcome measures
Edinburgh Postnatal Depression Scale (EPDS)
Number of participants with breast feeding success
Obstetric Quality of Recovery Score (OBSQ10)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MorphineExperimental Treatment1 Intervention
2mg preservative free morphine
Group II: SalinePlacebo Group1 Intervention
4 mL preservative free saline
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Preservative Free Morphine
2019
Completed Phase 4
~140

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
524,146 Total Patients Enrolled
Daniel Katz, MDPrincipal Investigator - Icahn School of Medicine at Mount Sinai
Icahn School Of Medicine At Mount Sinai, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital
5 Previous Clinical Trials
669 Total Patients Enrolled

Media Library

Preservative Free Morphine Clinical Trial Eligibility Overview. Trial Name: NCT04017442 — Phase 4
Opioid Use/Abuse Research Study Groups: Morphine, Saline
Opioid Use/Abuse Clinical Trial 2023: Preservative Free Morphine Highlights & Side Effects. Trial Name: NCT04017442 — Phase 4
Preservative Free Morphine 2023 Treatment Timeline for Medical Study. Trial Name: NCT04017442 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What hazards can be associated with utilization of Preservative Free Morphine?

"There is ample evidence supporting the safety of Preservative Free Morphine, with its Phase 4 trial status resulting in a score of 3."

Answered by AI

Are there any openings for volunteers in this clinical trial?

"Presently, this clinical trial is not actively searching for participants. Initially posted in October 2019 with the last update taking place on November 9th 2020, those seeking alternative trials can find 1153 studies recruiting patients suffering from depression and 54 others focusing on Preservative Free Morphine."

Answered by AI

How many people are actively participating in this medical research?

"Unfortunately, this medical trial has ceased patient recruitment. It was first listed on October 19th 2019 and last updated on November 9th 2022. For those searching for alternative studies relating to depression, currently 1153 trials are still accepting participants; additionally there are 54 Preservative Free Morphine studies with places available."

Answered by AI

Are there any related experiments with Preservative Free Morphine?

"Currently, 54 clinical trials are underway to research Preservative Free Morphine with 15 of them in Phase 3. While a significant number of these tests are taking place in Boston, MA, over one hundred and thirty-one locations have begun testing this drug."

Answered by AI

Who else is applying?

What state do they live in?
Wisconsin
How old are they?
18 - 65
What site did they apply to?
Mount Sinai Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery
Daniel Katz 2019. "Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04017442.
~25 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top